Chargement en cours...
Lrig1 is an estrogen regulated growth suppressor and correlates with longer relapse free survival in ERα-positive breast cancer
Lrig1 is the founding member of the “Lrig” family and has been implicated in the negative regulation of several oncogenic receptor tyrosine kinases including ErbB2. Lrig1 is expressed at low levels in several cancer types but is over-expressed in some prostate and colorectal tumors. Given this heter...
Enregistré dans:
| Auteurs principaux: | , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2011
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3196675/ https://ncbi.nlm.nih.gov/pubmed/21821674 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1541-7786.MCR-11-0227 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|